Oslo, Norway, 31 December 2019.

Participants in the Photocure ASA's share option program have on 31 December
2019 exercised a total of 150,168 options. The share options are exercised at
expiry on 31 December 2019 and at a strike price of NOK 32.78. Each option gives
a right to receive one share in the company. The share options are described in
note 7 in Photocure's annual financial statements for 2018.

Following the exercise, the Board of Directors, pursuant to authorisation
granted by the company's Annual General Meeting, has decided to increase the
company's share capital by NOK 75,084 by issuing up to 150,168 new shares, of
par value NOK 0.50.

The following options are exercised by primary insiders:

  · Erik Dahl, CFO, has exercised 24,000 options.
  · Grete Hogstad, VP Strategic Marketing, has exercised 24,000 options.
  · Gry Stensrud, VP Technical Development and Operation, has exercised 27,000
options.
  · Espen Njåstein, Head Nordic Cancer Commercial Operations, has exercised
23,300 options.

The primary insiders mentioned above is expected to transfer their rights to
receive shares resulting from the exercise of options to a third party. The
sales amount will be finally determined on the basis of the price subsequently
obtained by the third party in the market. The results of the sales process
including number of shares to be kept for primary insiders, as well as their
updated shareholdings, will be announced in a separate stock exchange notice
when known.

For further information, please contact:

Photocure
CFO Erik Dahl
Tel: +47 450 55 000, Email: ed@photocure.com

This information is subject to the disclosure requirements pursuant to sections
5-12 and 4-2 of the Norwegian Securities Trading Act.